Lexicon Pharma: Inpefa’s Early Clinical Benefits, Rehospitalization Data May Unlock Value
apomares/E+ via Getty Images Introduction & Thesis Shares of biopharma Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are ~60% off their May highs, ...
apomares/E+ via Getty Images Introduction & Thesis Shares of biopharma Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are ~60% off their May highs, ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.